Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Hochhaus

Showing results (1-10 of 81) with videos related to

Pageof 9
Sort By:
Pharmaceutical Research|August 1, 1995
Metabolism of dynorphin A 1-13 in human blood and plasmaS Müller, G Hochhaus
Drug Discovery Today|March 27, 2001
Methods used to assess pulmonary deposition and absorption of drugsC Mobley, G Hochhaus
Pharmaceutical Research|April 1, 1988
A biotin-avidin-based enzyme immunoassay for beta h-endorphinG Hochhaus, W Sadée
International Journal of Clinical Pharmacology, Therapy, and Toxicology|September 1, 1992
Pharmacokinetic/pharmacodynamic characteristics of the beta-2-agonists terbutaline, salbutamol and fenoterolG Hochhaus, H Möllmann
Die Pharmazie|June 24, 2004
Metabolism of dynorphin A(1-13)B Brugos, G Hochhaus
International Journal of Clinical Pharmacology and Therapeutics|January 7, 1999
Pharmacokinetic and pharmacodynamic aspects of salmeterol therapyA Buchwald, G Hochhaus
International Journal of Clinical Pharmacology and Therapeutics|May 6, 2004
Drugs used in the treatment of opioid tolerance and physical dependence: a reviewK Raith, G Hochhaus
Agents and Actions|June 1, 1990
Binding affinities of rimexolone (ORG 6216), flunisolide and their putative metabolites for the glucocorticoid receptor of human synovial tissueG Hochhaus, H W Moellmann
Die Pharmazie|August 1, 1996
Interspecies comparison of in vitro plasma degradation of dynorphin A 1-13S Müller, R Dunker, G Hochhaus
The Journal of Steroid Biochemistry and Molecular Biology|February 1, 1991
Soft drugs--10. Blanching activity and receptor binding affinity of a new type of glucocorticoid: loteprednol etabonateP Druzgala, G Hochhaus, N Bodor
Pageof 9

Showing results (1-10 of 81) with videos related to

Sort By:
Pageof 9
Pharmaceutical Research|August 1, 1995
Metabolism of dynorphin A 1-13 in human blood and plasmaS Müller, G Hochhaus
Drug Discovery Today|March 27, 2001
Methods used to assess pulmonary deposition and absorption of drugsC Mobley, G Hochhaus
Pharmaceutical Research|April 1, 1988
A biotin-avidin-based enzyme immunoassay for beta h-endorphinG Hochhaus, W Sadée
International Journal of Clinical Pharmacology, Therapy, and Toxicology|September 1, 1992
Pharmacokinetic/pharmacodynamic characteristics of the beta-2-agonists terbutaline, salbutamol and fenoterolG Hochhaus, H Möllmann
Die Pharmazie|June 24, 2004
Metabolism of dynorphin A(1-13)B Brugos, G Hochhaus
International Journal of Clinical Pharmacology and Therapeutics|January 7, 1999
Pharmacokinetic and pharmacodynamic aspects of salmeterol therapyA Buchwald, G Hochhaus
International Journal of Clinical Pharmacology and Therapeutics|May 6, 2004
Drugs used in the treatment of opioid tolerance and physical dependence: a reviewK Raith, G Hochhaus
Agents and Actions|June 1, 1990
Binding affinities of rimexolone (ORG 6216), flunisolide and their putative metabolites for the glucocorticoid receptor of human synovial tissueG Hochhaus, H W Moellmann
Die Pharmazie|August 1, 1996
Interspecies comparison of in vitro plasma degradation of dynorphin A 1-13S Müller, R Dunker, G Hochhaus
The Journal of Steroid Biochemistry and Molecular Biology|February 1, 1991
Soft drugs--10. Blanching activity and receptor binding affinity of a new type of glucocorticoid: loteprednol etabonateP Druzgala, G Hochhaus, N Bodor
Pageof 9